Stories from Our Federal Workers: HUD (Sunday, July 26, 2026) 2 to 3 p.m
Mitochondrial dynamics and bioenergetic alteration during inflammatory activation of astrocytes
Glutamate dehydrogenase in brain mitochondria: do lipid modifications and transient metabolon formation influence enzyme activity
Wie GLP-1-Medikamente den Blutzucker regulieren, Hunger und Sttigung beeinflussen und die Gewichtsreduktion bei Adipositas untersttzen knnen GLP-1-Rezeptor-Agonisten sind Medikamente, die die Wirkung des krpereigenen Darmhormons GLP-1 (Glucagon-like Peptide-1) nachahmen
Toxicol Sci 143(2):268276 Kumar BS, Chung BC, Kwon OS, Jung BH (2012) Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics
Eli Lillys new GLP-1 candidate orforglipron is expected to be filed for regulatory approval towards the end of 2025, with the earliest date of approval anticipated to be mid-2026